🌍World BusinessCandel Therapeutics Maintains Upgrade Following Prostate Treatment Filing Delay
Candel Therapeutics secured an analyst upgrade despite pushing back its prostate treatment filing, as the biotech firm continues advancing its engineered viral therapies.